The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C
Authors:
Open Access
- 1 December 2014
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46, S186-S196
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010Alimentary Pharmacology & Therapeutics, 2013
- Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic ComplicationsAmerican Journal of Preventive Medicine, 2013
- Current and Future Disease Progression of the Chronic HCV Population in the United StatesPLOS ONE, 2013
- Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edemaJournal of Hepatology, 2012
- Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modalityBMC Cancer, 2011
- Ribavirin in the treatment of chronic hepatitis CJournal of Gastroenterology and Hepatology, 2008
- Fatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus InfectionDigestive Diseases and Sciences, 2007
- Health-related quality of life in patients with chronic hepatitis C and advanced fibrosisJournal of Hepatology, 2007
- The effects of HCV infection and management on health-related quality of lifeHepatology, 2007
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993